Buy Kura Oncology Stock | KURA Stock Price & Latest News | Public.com
KURA

Kura Oncology

$0.00 (0.00%)Today
    View Kura Oncology (KURA) stock trends here

    About KURA

    Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Ch...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.15
    -0.3
    -0.45
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.43

    Actual EPS
    Q1 2021

    Stats

    Market Cap$1,96B
    Volume895,73k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$43.00
    1 Year Low$6.35
    Open$31.77
    High$31.77
    Low$27.89

    Buy any stock with any amount of money.

    Download the App
    Download the app